Other Grant Opportunities
These are grant opportunities offered by organizations other than HTRS.
Please contact the organization mentioned in the listing for more information.
THSNA Travel-To-A-Mentor Award Call for Applications
Each THSNA Travel-To-A-Mentor Award provides financial support (up to $2,500 per award) for one mentee to train for one week with a pre-selected research mentor at the mentor's facility anywhere in the US, Canada, or Mexico. Award funds will cover transportation, hotel/housing, meals, and essential incidental expenses.
Applicants must be a member of a THSNA member organization. HTRS is a member of THSNA.
The structure of each one-week experience will be determined jointly by the mentee and mentor, and is expected to include:
a) clinical and/or laboratory experiences (where applicable)
b) attendances at relevant conferences and laboratory or research group meetings
c) a meeting with the mentor to discuss potential future collaborations
Awards will fall into the following categories:
- Laboratory technologist/specialist
- PhD researcher
- Physician investigator, clinical, translational, or basic
- Patient advocate
Please find below the link to the complete Award Outline and Application Link.
For questions or assistance with locating a mentor, please contact THSNA at:
Email: [email protected]
NHBLI Grant Opportunities - submission deadlines are in July and October, 2018
The NHLBI Catalyzing Innovation in Late Phase Clinical Trial Design and Statistical Analysis Funding Opportunity Announcements (FOAs) have been recently published in the NIH Guide:
The purpose of these FOAs is to provide support for planning activities for late phase (phase II and beyond) single-site or multi-site investigator-initiated clinical trials that address critical clinical questions within the mission of the National Heart, Lung, and Blood Institute (NHLBI) and that require non-traditional clinical trial designs with the opportunity for statistical novelty and/or innovation.
Examples of scientific areas / clinical questions for which alternative approaches may be required:
- studies of rare diseases and/or therapeutics
- studies in sub-populations of more common diseases, e.g. precision medicine trials
- late-stage implementation research
- interventional trials for which
- non-randomized study setting is required
- optimal treatment control arm may be difficult to implement
- innovative design and analysis would result in optimizing trial efficiency and cost
The submission deadlines are in July and October, 2018.
For any questions about these FOAs from potential applicants planning a clinical trial in an area of blood science that is within the mission of NHLBI, please contact:
Dr Andrei Kindzelski, [email protected]